California Public Employees Retirement System
CBIO

California Public Employees Retirement System’s Crescent Biopharma CBIO Stock Holding History

California Public Employees Retirement System’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-541
Closed -$163K – 2096
2021
Q1 		$163K Hold
541
– – ﹤0.01% 3401
2020
Q4 		$203K Hold
541
– – ﹤0.01% 3347
2020
Q3 		$166K Hold
541
– – ﹤0.01% 3279
2020
Q2 		$203K Sell
541
-62
-10% -$17.6K ﹤0.01% 3158
2020
Q1 		$137K Hold
603
– – ﹤0.01% 3015
2019
Q4 		$319K Buy
603
+498
+474% +$270K ﹤0.01% 2927
2019
Q3 		$45K Buy
+105
New +$67.5K ﹤0.01% 3190
2018
Q2 		– Sell
-102
Closed -$166K – 3305
2018
Q1 		$166K Buy
+102
New +$212K ﹤0.01% 3031

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System's CBIO Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Crescent Biopharma (CBIO) in Q2 2021, closing a stake of 541 shares — an estimated $163K sold.

California Public Employees Retirement System first reported a position in CBIO in Q1 2018 and held it in 8 quarters. The position peaked at $319K in Q4 2019. 58 funds tracked by Wall St. Rank hold CBIO as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Crescent Biopharma position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 541 Crescent Biopharma shares in Q2 2021, an estimated $163K.
  • California Public Employees Retirement System first reported a position in Crescent Biopharma in Q1 2018 and held it in 8 quarters.
  • California Public Employees Retirement System's Crescent Biopharma position peaked at $319K in Q4 2019.
  • 58 funds tracked by Wall St. Rank held Crescent Biopharma as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.